ArticleBMC infectious diseases2026
Co-infection of SARS-CoV-2 and DENV case report in Jazan Region Southwest Saudi Arabia.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Co-infection with Dengue Virus (DENV) and SARS-CoV-2 presents a significant public health challenge, particularly in regions where dengue is endemic. Such cases have been reported in various countries, including Saudi Arabia, particularly in Jeddah. We report the first documented case of dengue and COVID-19 co-infection in the Jazan region of southwestern Saudi Arabia. A 41-year-old female presented with high fever, headache, fatigue, and pansinusitis-like symptoms. During her hospital admission, laboratory investigations revealed thrombocytopenia and severe leukopenia on a complete blood count (CBC) test, symptoms, and blood tests suggestive of dengue fever. RT-PCR confirmed concurrent DENV serotype 2 and COVID-19 infection. The patient was managed symptomatically with intravenous fluids and paracetamol, showing full recovery without complications. This case highlights the need for simultaneous testing and careful differentiation between DENV and SARS-CoV-2 infections in endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.